Shatavari root extract for women's sexual wellness

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, placebo-controlled, parallel-group trial enrolling sexually active women aged 20–50 with reduced sexual function and elevated perceived stress. Participants are randomized 1:1 to receive 300 mg/day of a standardized Shatavari (Asparagus racemosus) root extract (SRI-81) or matched placebo for 12 weeks, with baseline and follow-up visits. The primary efficacy measure is the Female Sexual Function Index (FSFI), with secondary outcomes including sexual distress, sexual satisfaction, perceived stress, quality of life, salivary cortisol, and routine laboratory safety tests. Safety is monitored via adverse event reporting and laboratory assessments throughout the treatment period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Women between 20 to 50 years of age.
2. Sexually active, attempting sexual activity, or experiencing concerns related to sexual desire or function, with a partner and have a FSFI total score ≤ 26.55.
3. Have a PSS-10 score of ≥ 14 at screening.
4. Women presenting with signs and symptoms suggestive of stress (e.g., difficulty, concentrating, physical exhaustion, anxiety, restlessness, insomnia, headache, fatigue, loss of appetite, worry, sweating, mental confusion, etc.).
5. Participants who are reliable, honest, compliant, and agree to co operate with all trial evaluations as well as to be able to perform them as per investigator's opinion.
6. Participants having sufficient understanding to communicate effectively with the investigator and are willing to discuss their sexual functioning with the investigative staff.
7. Able to read and write in English or any other vernacular language.
8. No plan to commence new treatments over the study period.
9. Must have the ability and willingness to sign a written informed consent and to comply with all study procedures.

Exclusion Criteria:

1. Participants taking any form of herbal extract in the last 3 months before study entry.
2. Participants with hormonal imbalance including PCOS, and symptoms of perimenopause and menopause
3. Participants who are on hormone replacement therapy (HRT) for more than 3 months.
4. Participants with any active medical, surgical, or gynaecological problems.
5. Participants with a history of alcohol, tobacco dependence, or any other substance abuse
6. Participants with clinically relevant cardiovascular, gastrointestinal, hepatic, neurologic, endocrine, haematologic or other major systemic diseases making implementation of the protocol or other interpretation of the study result difficult.
7. Participants with mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
8. Participants with demonstrated inability to comply with the study procedures, including poor compliance.
9. Participants with inability to attend follow-up visits.
10. Patients with known hypersensitivity to Shatavari, or any of the ingredients of study interventions.
11. Patients who had participated in other clinical trials during the previous 3 months.
12. Patients who have any clinical condition, according to the investigator who does not allow safe fulfilment of clinical trial protocol.

Where it's running

• San Francisco Research Institute
  San Francisco, California, United States Recruiting

Study contacts

• Study coordinator: Dr. John Ademola
• Email: jademola@sfinstitute.com
• Phone: 415-845-4638

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity

  This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.

  Recruiting George Washington University · Washington D.C., District of Columbia · NCT07724522

• Seated Tai Chi/Qigong for Women with Mobility Impairments delivered at home

  A remotely delivered seated Tai Chi/Qigong program is being tested to see if it improves cardiometabolic health, stress, sleep, and well-being in women with mobility impairments.

  Recruiting Arizona State University · Phoenix, Arizona · NCT07675681

• Sexual well-being in people treated for gynecologic cancer and their partners

  This project will follow people with gynecologic cancer and their partners to see if their sexual function changes over time using questionnaires and brief exams.

  Recruiting Casa di Cura Dott. Pederzoli · Bologna, Bologna and 5 other locations · NCT07557342

• Sexual well-being after mastectomy and immediate reconstruction

  We will collect short electronic questionnaires from women having mastectomy with immediate reconstruction to see how the surgery affects sexual well‑being.

  Recruiting European Institute of Oncology · Bari, Italy and 18 other locations · NCT07234461

• Daily lemongrass tablets with HIIT to try to improve aerobic fitness in middle-aged men

  This trial will test whether taking a daily lemongrass tablet while doing a 6-week supervised high-intensity interval training program can improve aerobic fitness and sexual wellness in men aged 40–60.

  Recruiting Northumbria University · Newcastle upon Tyne · NCT07195240

• Exploring the Asian-Mediterranean diet's impact on women's health

  This study is testing whether a Mediterranean-style diet designed for Asian women can improve heart and metabolic health in women aged 21-50 in Singapore.

  Recruiting Global Centre for Asian Women's Health · Singapore, Singapore · NCT06825936

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.